Clinical Research

As part of UCSF’s Spring 2019 RAP funding cycle, CTSI is offering a new pilot award (up to $40,000) to support research projects focused on the prevention and treatment of opioid disorders.

Story posted via UCSF.edu

Reducing the Need for Non-Preventive Healthcare Utilization in the First Month of Life

The Trial Innovation Network (TIN) is a collaborative initiative within the CTSA Program and is composed of three key partners – the CTSA Program Hubs, the Trial Innovation Centers (TICs), and the Recruitment Innovation Center (RIC).

Note: CTSI supported study - former KL2 Scholar Sabine Mueller along with former Catalyst awardee Hideho Okada are leading the phase I clinical trial of this research.

UCSF Research Leads to a Clinical Trial of New Cancer Vaccine and Development of Cell Therapy Approaches

Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells, according to a new study led by UC San Francisco researchers.

Originally posted to the UC CIO blog here

Note: The study was supported by funding from the National Institutes of Health and the Clinical and Translational Science Institute at UCSF.

By Suzanne Leigh

The protective effects of probiotics against colds, tummy bugs and more serious conditions have been exalted – and contested. Now a new study headed by UC San Francisco researchers further fuels the probiotics debate by finding that there is no clear evidence that a supplement of the “friendly” bacteria strain of lactobacillus prevents eczema, a frequent precursor to asthma.